INOD Innodata Inc.
Innodata Inc. operates as a data engineering company in the United States, the United Kingdom, the Netherlands, Canada, Germany, Belgium, and internationally. The company operates through three segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment engages in the provision of artificial intelligence (AI) training and post-training data, model evaluation, alignment, safety, AI model deployment and integration, and AI-enabled platforms. The Synodex segment offers an industry platform that transforms medical records into structured digital data for insurance and healthcare workflows. The company also provides Agility PR Solutions platform that provides media intelligence and public relations workflow software enhanced with AI-driven monitoring, analytics, and content capabilities; and operates R&D laboratory that generate the data needed to train the human-like robots and validate the performance data. It serves banking, insurance, financial services, technology, digital retailing, and information media sectors through its professional staff, senior management, and direct sales personnel. The company was formerly known as Innodata Isogen Inc. and changed its name to Innodata Inc. in November 2003. Innodata Inc. was incorporated in 1988 and is headquartered in Ridgefield Park, New Jersey.…
Industry Peers
Information Technology ServicesKey Statistics
About Innodata (NASDAQ: INOD)
›
Innodata (NASDAQ: INOD) is listed on Nasdaq, where its shares trade in USD. It belongs to the Information Technology Services industry, part of the Technology sector, and reports about 10,020 employees.
The shares were at 30.87 USD on 19 November 2026, down 49.3% over 52 weeks. Its 52-week range is 30.71 USD to 125.14 USD, and it trades at the bottom of that range.
At a market capitalisation of 1.06B USD, it trades at 22.4 times trailing earnings and 16.4 times forward earnings. The median trailing P/E of its 20 largest Information Technology Services peers is 15.2, a premium of 47% for INOD.
Innodata reports return on equity of 30.0%, an operating margin of 14.9% and revenue up 52.9% year over year.
It holds more cash than debt, a net cash position of 160.44M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 111.50 USD is 261.2% above the current price. The next earnings report is expected on 25 February 2027.